1. Home
  2. TRTX vs NVCT Comparison

TRTX vs NVCT Comparison

Compare TRTX & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TPG RE Finance Trust Inc.

TRTX

TPG RE Finance Trust Inc.

HOLD

Current Price

$8.37

Market Cap

659.4M

Sector

Real Estate

ML Signal

HOLD

Logo Nuvectis Pharma Inc.

NVCT

Nuvectis Pharma Inc.

HOLD

Current Price

$18.39

Market Cap

721.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRTX
NVCT
Founded
2014
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
659.4M
721.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
TRTX
NVCT
Price
$8.37
$18.39
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$9.83
$10.00
AVG Volume (30 Days)
685.5K
276.8K
Earning Date
04-28-2026
05-06-2026
Dividend Yield
11.55%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.78
N/A
Revenue Next Year
$4.14
N/A
P/E Ratio
$14.82
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.57
$5.55
52 Week High
$9.85
$29.28

Technical Indicators

Market Signals
Indicator
TRTX
NVCT
Relative Strength Index (RSI) 45.38 55.77
Support Level $8.35 $6.93
Resistance Level $8.73 N/A
Average True Range (ATR) 0.14 2.55
MACD -0.02 1.19
Stochastic Oscillator 26.53 44.96

Price Performance

Historical Comparison
TRTX
NVCT

About TRTX TPG RE Finance Trust Inc.

TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating-rate first mortgage loans that are secured by high-quality commercial real estate properties undergoing some form of transition and value creation.

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

Share on Social Networks: